De Jonghe, Joachim https://orcid.org/0000-0003-0584-8265
Kim, Hyung Chul https://orcid.org/0000-0001-5877-5456
Adedeji, Ayanfeoluwa https://orcid.org/0009-0007-5095-7539
Leitão, Elsa https://orcid.org/0000-0001-5051-9714
Dawes, Ruebena https://orcid.org/0000-0003-2135-0117
Kajba, Christina M. https://orcid.org/0000-0002-7896-0744
Cogné, Benjamin https://orcid.org/0000-0002-5503-6292
Chen, Yuyang https://orcid.org/0000-0001-5593-6920
Blakes, Alexander J. M. https://orcid.org/0000-0002-0260-7020
Simons, Cas https://orcid.org/0000-0003-3147-8042
Rius, Rocio https://orcid.org/0000-0002-9871-3126
Alvi, Javeria R.
Amblard, Florence
Austin-Tse, Christina
Baer, Sarah
Balton, Elsa V.
Blanc, Pierre
Calame, Daniel G.
Coutton, Charles
Cunningham, Chloe A. https://orcid.org/0000-0002-2525-1936
Dargie, Nitsuh
Dipple, Katrina M.
Du, Haowei https://orcid.org/0000-0001-9052-1587
El Chehadeh, Salima https://orcid.org/0000-0003-1613-6570
Glass, Ian https://orcid.org/0000-0001-6762-8407
Gleeson, Joseph G. https://orcid.org/0000-0002-0889-9220
Grunewald, Olivier
Gueguen, Paul
Harbuz, Radu
Jacquemont, Marie-Line
Leventer, Richard J.
Marijon, Pierre https://orcid.org/0000-0002-6694-6873
Messaoud, Olfa https://orcid.org/0000-0003-4547-0180
Sultan, Tipu
Thauvin, Christel https://orcid.org/0000-0002-4155-139X
Vincent-Delorme, Catherine
Yilmaz Gulec, Elif
Thevenon, Julien
Mendez, Rodrigo https://orcid.org/0000-0001-6465-452X
MacArthur, Daniel G.
Depienne, Christel https://orcid.org/0000-0002-7212-9554
Nava, Caroline https://orcid.org/0000-0003-1272-0518
Whiffin, Nicola https://orcid.org/0000-0003-1554-6594
Findlay, Gregory M. https://orcid.org/0000-0002-7767-8608
Article History
Received: 24 April 2025
Accepted: 26 February 2026
First Online: 8 April 2026
Competing interests
: N.W. receives research funding from Novo Nordisk and Biomarin Pharmaceutical. D.G.M. is a paid consultant for GlaxoSmithKline, Insitro and Overtone Therapeutics and receives research support from Microsoft. The other authors declare no competing interests.